Quantum HealthcareQTHLF +20.00% 3-Year RORE % is 0.00 as of Mar. 2026. The stock has 3 warning signs investors should review. Among 782 Medical Devices & Instruments companies, Quantum Healthcare ranks worse than 127877.11% on this metric.
Return on Retained Earnings (RORE) is an indicator of a company's growth potential, it shows how much a company earns by reinvesting its retained earnings, i.e. profits after dividend payments.
Quantum Healthcare does not have enough data to calculate 3-Year RORE %.
Return on Retained Earnings (RORE) is important to investors because it reveals a company's efficiency and growth potential. A higher RORE indicates a higher return. A high RORE indicates that the company should reinvest profits into the business. A lower RORE suggests that the company should distribute profits to shareholders by paying out dividends, since those dollars aren't generating much additional growth for the company.
There are a several different ways to arrive at the Return on Retained Earnings. The simplest way to calculate it is by using published information on Earnings per Share (EPS) and Dividend per Share (DPS) over a selected period. Here, 3-year period is chosen.
Be Aware
Please keep in mind that the RORE is relative to the nature of the business and its competitors. If another company in the same sector is producing a lower return on retained earnings, it doesn’t necessarily mean it’s a bad investment. It may just suggest the company is older and no longer in a high growth stage. At such a stage in the business cycle, it would be expected to see a lower RORE and higher dividend payout.
Quantum Healthcare 3-Year RORE % Related Terms
Quantum Healthcare 3-Year RORE % Historical Data
* Premium members only.
The historical data trend for Quantum Healthcare's 3-Year RORE % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Quantum Healthcare's 3-Year RORE %, along with its competitors' market caps and 3-Year RORE % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Quantum Healthcare 3-Year RORE % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Quantum Healthcare's 3-Year RORE % distribution charts can be found below:
* The bar in red indicates where Quantum Healthcare's 3-Year RORE % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of 3-Year RORE %, the most recent and first period EPS (Diluted) is the trailing twelve months (TTM) data ended in Mar. 2026 and 3-year before.
Quantum Healthcare (QTHLF) has a 3-Year RORE % of 0.00 as of Mar. 2026. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Quantum Healthcare and its competitors. According to the industry distribution chart, Quantum Healthcare ranks #999999 out of 782 companies in the Medical Devices & Instruments industry.
Is Quantum Healthcare's 3-Year RORE % too high?
Quantum Healthcare's current 3-Year RORE % is 0.00. Based on the distribution chart, Quantum Healthcare ranks #999999 out of 782 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Quantum Healthcare's 3-Year RORE % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Quantum Healthcare ranks #999999 out of 782 companies for 3-Year RORE %. This places Quantum Healthcare in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year RORE % for a Medical Devices & Instruments company?
A good 3-Year RORE % depends on the Medical Devices & Instruments industry context. However, 3-Year RORE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year RORE % mean?
A high 3-Year RORE % can signal that a stock is expensive relative to its fundamentals. 3-Year RORE % shows how much a company earns by reinvesting its retained earnings in 3-year. View historical data on Quantum Healthcare and its competitors. Quantum Healthcare's current 3-Year RORE % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Quantum Healthcare stock overvalued right now?
Quantum Healthcare (QTHLF) has a current 3-Year RORE % of 0.00. The current 3-Year RORE % is 0.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year RORE % calculated?
3-Year RORE % is calculated from a company's financial statements. For Quantum Healthcare (QTHLF), the current 3-Year RORE % is 0.00 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Quantum Healthcare Ltd formerly QT Vascular Ltd engages in the development and distribution of therapeutic solutions for the treatment of vascular diseases. It designs, assembles, and distributes therapeutic solutions for the minimally invasive treatment of complex vascular diseases. Healthcare Business also includes the provision of dental services, and Corporate business includes operations management and consultancy services. Company provides services which includes the research, development, and design of medical equipment and other related products of geriatric medical rehabilitation equipment and others.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
QTHLF has been successfully added to your 